benefits of microdosing glp-1 THE PCCA BLOG Microdosing GLP-1s: Reduce Inflammation, Support
Description
Accessed August 12, 2025

Table 5 summarizes the results from cardiovascular studies

Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, de Luca M, Faria SL, Goodpaster KPS, Haddad A, Himpens JM, Kow L, Kurian M, Loi K, Mahawar K, Nimeri A, O'Kane M, Papasavas PK, Ponce J, Pratt JSA, Rogers AM, Steele KE, Suter M, Kothari SN
Tracking liver enzymes alongside metabolic markers like HbA1c and lipids gives you a complete picture
Obesity is also associated with both increased PsA incidence and reduced therapeutic response to biologic agents (23, 24)

The safer question is: which treatment fits the patients health profile Retatrutide vs Tirzepatide vs Semaglutide Is Retatrutide FDA Approved
